Plasma homocysteine status in patients with ankylosing spondylitis

@article{Wei2006PlasmaHS,
  title={Plasma homocysteine status in patients with ankylosing spondylitis},
  author={James Cheng-Chung Wei and Ming-shiou Jan and Chen-Tung Yu and Yi-Chia Huang and Chi-Chiang Yang and Hsi-Kai Tsou and Hong-Shan Lee and Chang-Tei Chou and Gregory Jiazer Tsay and Ming-chih Chou},
  journal={Clinical Rheumatology},
  year={2006},
  volume={26},
  pages={739-742}
}
  • James Cheng-Chung Wei, Ming-shiou Jan, +7 authors Ming-chih Chou
  • Published in Clinical Rheumatology 2006
  • Medicine
  • Homocysteine (Hcy), a sulfur-containing amino acid, is eliminated through B vitamins-dependent pathways. Hyperhomocysteinemia has been found to be an independent risk factor for atherosclerotic cardiovascular, cerebrovascular, and peripheral vascular diseases. Recently, psoriasis, lupus, and rheumatoid arthritis were reported to be associated with hyperhomocysteinemia. This study was aimed to evaluate the changes of plasma Hcy level before and after sulfasalazine and MTX therapy in patients… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 13 CITATIONS

    Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor.

    • Xiaolin Li, Tian-tian Lin, +4 authors Jing Lu
    • Medicine
    • Journal of investigative medicine : the official publication of the American Federation for Clinical Research
    • 2013

    Spondyloarthritis in China o pyright

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Serum levels of IL-33 is increased in patients with ankylosing spondylitis

    VIEW 1 EXCERPT
    CITES BACKGROUND

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 11 REFERENCES

    Homocysteine modification of HLA antigens and its immunological consequences.

    VIEW 1 EXCERPT